Jeffrey A Meckler
CIK 1506916 · Co-Chief Executive Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$8.12M
Companies
5
Total Filings
55
Lifetime Open-Market Net
$122.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 91,500 | $52.04 | $4.76M | -$922.3K | 8 | 2026-05-21 |
| INDP | Co-Chief Executive Officer | 229,929 | $3.58 | $823.1K | $273.6K | 17 | 2026-02-13 |
| Intec Pharma Ltd. (NTEC) Delisted | Chief Executive Officer | 196,761 | $9.63 | $1.89M | $59.3K | 4 | 2020-07-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 64,000 | — | — | $350.1K | 10 | 2020-05-19 |
| QLTI | Director | 94,500 | $26.82 | $2.53M | $362.0K | 10 | 2016-06-21 |
Recent Filings · Page 5 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-01 | QLTI | Exer (M) | +25,000 | $87.1K | EDGAR |
| 2015-06-10 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +2,000 | $0 | EDGAR |
| 2015-06-09 | QLTI | Exer (M) | +10,000 | $0 | EDGAR |
| 2015-03-27 | — | Buy (P) | +163,043 | $150.0K | |
| 2015-03-25 | — | Grant (A) | — | $0 | |
| 2014-12-19 | QLTI | Mixed | +20,000 | $72.0K | EDGAR |
| 2014-12-17 | QLTI | Exer (M) | +2,000 | $0 | EDGAR |
| 2014-12-15 | — | Buy (P) | +100,000 | $45.6K | |
| 2014-11-25 | Travere Therapeutics, Inc. (RTRX) Delisted | Buy (P) | +15,000 | $129.0K | EDGAR |
| 2014-10-10 | Travere Therapeutics, Inc. (RTRX) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.